EVOLVE2CARE at ISPIM Connects Bangkok 2026

EVOLVE2CARE was presented at ISPIM Connects Bangkok 2026 (9–11 March), an international forum bringing together researchers, industry experts, and policymakers to exchange knowledge on innovation management and its real-world applications.

Addressing the Gap in Clinical Practice 

During the event, Evdokimos Konstantinidis from Aristotle University of Thessaloniki (AUTH) represented the EVOLVE2CARE through a presentation titled “Leveraging Living Labs to Integrate Research into Clinical Practice”, highlighting how Living Lab methodologies can support the adoption of digital health solutions in transitional care.

A central focus of the presentation was the persistent challenge of integrating research into everyday clinical settings. Drawing on findings from research involving Living Lab practitioners, Konstantinidis highlighted that while integration is essential, healthcare professionals face several critical obstacles:

  • Time Constraints: Heavy workloads often leave little room for research activities. 
  • Competing Care Priorities: Immediate clinical needs frequently take precedence over long-term research objectives. 
  • Misalignment: There is often a gap between research goals and actual clinical needs, coupled with a lack of aligned incentives for practitioners. 

The presentation emphasized that Living Lab methodologies are key to overcoming these barriers. By providing structured environments for co-creation and real-world testing, Living Labs act as enablers for transitional care innovation by: 

  • Improving Relevance: Ensuring research activities directly address clinical needs. 
  • Fostering Co-ownership: Engaging healthcare professionals directly in the innovation process. 
  • Enabling Collaboration: Facilitating multi-stakeholder partnerships between researchers and clinicians. 
  • Supporting Validation: Testing and validating solutions within real care settings to ensure they work in practice. 

These insights align with EVOLVE2CARE’s broader mission to bridge the gap between innovation and implementation within healthcare systems.

Integrating research into everyday clinical settings remains a key challenge in healthcare innovation. Healthcare professionals often face barriers such as limited time, competing care priorities, and misalignment between research objectives and clinical needs. 

The EVOLVE2CARE contribution addressed these challenges by presenting findings from research involving Living Lab practitioners. The results underline that time constraints and lack of aligned incentives are among the most critical obstacles to integrating research into practice. 

From experimentation to Real-World Impact

Moving beyond theory, EVOLVE2CARE showcased its practical approach to supporting innovators through its experimentation frameworks. Rather than just providing theoretical guidance, the project matches innovators with Living Labs through a dedicated Open Call.

Under this model, selected innovators receive specialized experimentation services from certified Living Lab infrastructures to test their HealthTech solutions. The costs for these services are covered by the project’s Open Call budget, ensuring that financial barriers do not hinder the validation of high-impact technologies. 

Participation in ISPIM Connects Bangkok 2026 highlights EVOLVE2CARE’s contribution to international discussions on HealthTech innovation, Living Labs, and the integration of research into clinical practice.

Advancing Regulatory Learning in HealthTech through EVOLVE2CARE Workshops

Behind effective HealthTech innovation lies not only strong technology, but also a clear understanding of the regulatory environment in which it operates.

As part of its work on transitional care, EVOLVE2CARE organised two dedicated workshops in February and March 2026, bringing together innovators, Living Labs, researchers, and policymakers to explore how regulatory learning can support the real-world adoption of digital health solutions.

Workshop 1: Understanding regulatory barriers in transitional care

The first workshop, “Understanding Regulatory Barriers and Enablers in Transitional Care”, took place on 25 February 2026, gathering 19 participants in an interactive session focused on identifying key regulatory challenges.

The session introduced the concept of regulatory learning and explored how Living Labs can contribute to navigating complex regulatory environments. Through a hands-on exercise using a collaborative Miro board, participants shared real experiences, highlighting barriers related to compliance, policy fragmentation, and implementation constraints.

Beyond identifying challenges, the discussion also focused on potential solutions. Participants exchanged strategies for addressing regulatory obstacles and proposed policy measures that could better support innovation in transitional care.

Workshop 2: From insights to ecosystem-level discussion

Building on these initial findings, EVOLVE2CARE contributed to the ENoLL Joint Working Group on Regulatory Learning, relaunched on 4 March 2026, which brought together 61 participants.

During this session, EVOLVE2CARE presented the first results from the workshop and the regulatory learning survey, contributing to a wider discussion involving the Joint Research Centre (JRC) and Living Lab practitioners across Europe.

The workshop also featured best practice examples, illustrating how regulatory learning approaches are already being applied in real settings. Participants reflected on key questions around skills development, capacity building, and the role of collaborative frameworks in supporting regulatory adaptation.

Across both sessions, a clear message emerged: regulatory challenges remain a major barrier to scaling digital health solutions, but they can be addressed through structured, collaborative approaches. 

The Vital Role of Living Labs

Across both sessions, a clear message emerged: regulatory challenges remain a major barrier to scaling digital health solutions, but they can be adA recurring theme across both workshops was that while regulatory challenges are significant, they are manageable through structured, collaborative approaches. Living Labs are central to this effort because they enable: 

  • Real-world testing: Validating solutions in actual care environments. 
  • Early identification: Spotting regulatory constraints before they become roadblocks. 
  • Stakeholder collaboration: Building stronger ties between innovators, healthcare providers, and policymakers. 

Looking Ahead

The work continues with a third workshop scheduled for May 2026. This upcoming session will focus on translating workshop and survey data into actionable recommendations, capacity-building activities, and policy-oriented outcomes for the HealthTech ecosystem.

By fostering this ongoing dialogue, EVOLVE2CARE aims to bridge the gap between innovation and implementation, creating a more responsive regulatory environment for the future of healthcare.

From Applications to Experimentation: The Journey Behind the EVOLVE2CARE Open Call

Behind every successful experimentation phase lies a carefully designed selection process.

For EVOLVE2CARE, the Open Call was not simply a call for proposals. It was the foundation of a structured pathway connecting HealthTech innovators with Living Labs across Europe. The Open Call marked the transition from interest to engagement, and from ideas to implementation.

This blog builds on insights from Deliverable D2.2 – “Living Labs, Innovators and Researchers Scouting and Selection Report”, which is publicly available on Zenodo and provides a transparent overview of the scouting, evaluation, and selection process behind the EVOLVE2CARE Open Call.

Designing an Open Call with Purpose

HealthTech innovation thrives when solutions are tested where care actually happens. With this in mind, the EVOLVE2CARE Open Call focused on identifying innovators and Living Labs ready to collaborate in three critical domains of transitional care:

  • Hospital discharge management
  • Remote monitoring and home-based care
  • Ageing and chronic care support

The objective was not only to select promising technologies, but to ensure alignment between innovators’ ambitions and the real-world experimentation capacity of Living Labs.

A Structured and Transparent Process

The scouting and selection process was designed to be clear, fair, and impact-oriented.

Applications were evaluated against predefined criteria that considered:

  • Relevance to transitional care use cases
  • Technical feasibility and maturity
  • Potential for measurable impact
  • Readiness for collaboration within Living Lab environments

Beyond scoring, the process also focused on matchmaking, ensuring that selected innovators were paired with Living Labs capable of supporting meaningful experimentation.

This structured approach ensures that the experimentation phase is grounded in strategic alignment rather than opportunistic selection.

From Selection to Real-World Validation

With the Open Call phase completed, selected mini-projects have now entered Living Lab environments for real-world experimentation.

This marks a critical shift. The focus moves:

  • From proposal quality to implementation performance
  • From theoretical value to practical usability
  • From innovation potential to measurable impact

Within Living Labs, solutions are tested in real healthcare contexts, involving professionals, patients, and ecosystem actors. This enables innovators to refine their tools, identify integration challenges early, and generate evidence that goes beyond technical feasibility.

Building Evidence for Sustainable Uptake

The Open Call was the first step in a broader journey toward sustainability and scalability.

By documenting the scouting and evaluation methodology, EVOLVE2CARE reinforces its commitment to transparency and replicability. The structured selection process lays the groundwork for credible experimentation outcomes, stronger positioning of project results, and future ecosystem adoption.

Readers interested in understanding the full methodology behind the Open Call scouting and selection process can explore Deliverable D2.2 – “Living Labs, Innovators and Researchers Scouting and Selection Report”, available publicly on Zenodo.

From applications to experimentation, EVOLVE2CARE continues to build a pathway where innovation is not only selected, but validated, strengthened, and positioned for real-world healthcare transformation.

EVOLVE2CARE in Athens: Aligning for Impact and Sustainability

On 17–18 February 2026, the EVOLVE2CARE consortium met in Athens, Greece, for its 4th Plenary Meeting. Held in parallel with Athens Digital Health Week 2026 (ADHW2026) at the Royal Olympic Hotel, the gathering offered more than just coordination updates, it created a moment to reflect, realign, and strengthen the project’s next phase within Europe’s rapidly evolving digital health landscape.

Across two intensive days, partners focused on consolidating the Open Call results, reinforcing the EVOLVE2CARE experimentation framework, advancing the positioning of AccelUP, and scaling outreach and sustainability efforts.

Day 1: From Open Call Results to Real-World Experimentation

The first day was dedicated to a pivotal transition point for the project: moving from Open Call completion to structured implementation in Living Lab environments.

Reflecting on the Open Call Impact

With the Open Calls now officially finalised, the consortium reviewed:

  • Key statistics and insights from the application and selection process
  • Improvements introduced through Deliverable D2.2
  • The shift from recruitment to real-world pilot implementation

Beyond numbers, the discussion focused on impact. How can the lessons learned from the Open Call strengthen communication materials and support the long-term positioning of project outcomes?

The emphasis is now clear: experimentation must generate measurable, documented value within Living Labs.

Strengthening the EVOLVE2CARE Experimentation Framework

Day 1 also included final roadmap presentations for three central deliverables shaping the project’s experimentation model:

  • D1.4 – Roadmap on navigating complexities enabling innovative technologies in transitional care
  • D1.5 – Stakeholder Needs Analysis and KPI Framework
  • D1.6 – EVOLVE2CARE Action Plan

Concrete decisions were taken to reinforce structure and comparability across pilots:

  • Each mini-project will submit a structured “initial context” (solution, target users, key assumptions) before pilots begin, enabling meaningful before/after analysis.
  • A Regulatory & Ethics Log will allow Living Labs to systematically record compliance and data-related issues during implementation.
  • The KPI framework will be disseminated beyond the consortium, engaging relevant European health clusters and sister projects.

Day 2: Connecting Ecosystem Dialogue with Strategic Planning

The second day blended external engagement at ADHW2026 with focused internal alignment on evaluation, outreach, and long-term sustainability.

Engaging the Digital Health Ecosystem at ADHW2026

On the morning of 18 February, EVOLVE2CARE hosted the workshop:

“Engaging the Value of Living Labs to Innovate Healthcare”

Chaired by Despoina Petsani (AUTH), the session brought together innovators, clinicians, researchers, and ecosystem actors to tackle a pressing HealthTech question:

How can promising digital solutions successfully transition from pilot testing to routine clinical practice?

The discussion went beyond technology development and addressed the structural realities of healthcare innovation, including regulatory complexity, GDPR compliance, interoperability limitations, integration into clinical workflows, and fragmented stakeholder collaboration.

Across contributions, Living Labs emerged as structured experimentation environments capable of reducing deployment risks while generating real-world validation.

🔗 Read the full workshop recap here.

Aligning the Next Phase of the Project

Returning to the plenary discussions, partners focused on shaping the next phase of EVOLVE2CARE.

The agenda centred on five strategic priorities:

  • Structuring the evaluation framework for mini-project experimentation
  • Aligning questionnaires and feedback tools for innovators and Living Labs
  • Strengthening AccelUP’s positioning beyond the Open Call phase
  • Expanding participation in European Commission and EIT-related events
  • Planning sustainability and exploitation activities for all project results

Key Highlights from the Discussions

  • Evaluation tools were aligned to ensure structured before/after feedback capturing both technical and market-oriented value.
  • Pricing perception and value-creation questions were integrated into experimentation surveys.
  • Complementary assessment mechanisms were coordinated to ensure systematic data collection.
  • The exploitation approach was further defined, combining questionnaire-based validation with market and competitor analysis.
  • Dissemination efforts will intensify in the “Global Outreach & Sustainability” phase, with stronger participation in European-level events, broader press outreach, and enhanced digital engagement.
  • Strategic planning began for participation in Open Living Lab Days and policy-oriented events to showcase the project’s KPI framework and experimentation insights.

Key Decisions Moving Forward

  • Mini-project evaluation will follow a structured, comparable methodology capturing both experimentation outcomes and market insights.
  • Two internal exploitation workshops will be organized. One dedicated to AccelUP positioning, and another focusing on the remaining project results.
  • Outreach efforts will prioritise European Commission–related events and EIT KIC engagement.
  • Communication efforts will intensify, with coordinated partner promotion and increased focus on subscriber growth and stakeholder engagement.

A Strategic Transition Point

The 4th Plenary Meeting marked a clear evolution for EVOLVE2CARE:

  • From Open Call recruitment to structured pilot implementation
  • From framework design to measurable evidence generation
  • From awareness-building to strategic European outreach
  • From experimentation to sustainability planning

With mini-projects underway, evaluation tools aligned, and exploitation strategy defined, EVOLVE2CARE moves forward with a clearer pathway toward scalable, validated, and ecosystem-integrated HealthTech innovation!

Bridging the Digital Health Innovation Gap – ADHW26 Workshop Recap

Organised by the EVOLVE2CARE project in the context of Athens Digital Health Week 2026, the workshop “Engaging the Value of Living Labs to Innovate Healthcare” took place on 18 February and was chaired by Despoina Petsani, Project Mission Coordinator (AUTH). The session convened innovators, researchers, and ecosystem actors to examine a pressing question in HealthTech: how can promising digital solutions successfully transition from pilot testing to routine clinical practice?

Rather than focusing solely on the generation of new technologies, the discussion addressed the structural and operational barriers that prevent digital health innovations from scaling within real healthcare environments. Speakers highlighted a persistent misalignment between technological development and clinical realities. Digital tools frequently struggle to integrate into established workflows, while regulatory complexity, GDPR compliance, interoperability limitations, and fragmented stakeholder collaboration continue to slow adoption . This creates tension between rapid technological advancement and the healthcare sector’s demand for rigorous validation and governance, often resulting in solutions that are technically robust but operationally stalled.

Spyridoula Trakaki emphasised that startups commonly face systemic barriers to market entry and underscored the importance of open innovation ecosystems in overcoming fragmentation and accelerating uptake. Complementing this perspective, Konstantina Kostopoulou, Chief Product Owner of the Healthentia App, shared practical insights into integration pain points during experimentation, particularly around stakeholder engagement and the initial reactions of clinicians and third parties to new digital tools . Her intervention reinforced the idea that adoption depends not only on technological robustness but also on early trust-building and alignment with end-user expectations.

From a service design standpoint, Thanos Loules and Ilias Rafail of IASIS AMKE explored the challenges of developing inclusive services while maintaining active citizen engagement throughout the experimentation process . They stressed that meaningful co-creation requires sustained involvement rather than superficial consultation. Dr. Angelina Kouroubali further addressed the delicate balance between thorough research and the urgency to bring solutions to market, suggesting that structured experimentation frameworks can reconcile scientific rigor with innovation speed .

Across contributions, Living Labs emerged as a strategic integration mechanism. By enabling structured testing within authentic care settings, they reduce deployment risks, strengthen collaboration among stakeholders, and generate the field-based validation required for broader adoption . Rather than positioning digital tools as external add-ons, Living Labs facilitate their evolution into embedded components of care delivery systems.

The workshop ultimately underscored that sustainable healthcare transformation depends on aligning fast-moving innovation cycles with the operational and regulatory realities of the care sector. Through open ecosystems and Living Lab methodologies, stakeholders can bridge this divide—ensuring that digital health innovations are interoperable, credible, and capable of delivering measurable value in real-world clinical settings .

EVOLVE2CARE Contributes to Open Science at the ManagiDiTH Winter School 2026

EVOLVE2CARE was featured during the ManagiDiTH Winter School and Innovation Bootcamp 2026, held in Finland from 26–30 January 2026, an intensive five-day programme combining innovation, entrepreneurship, and hands-on collaboration in the field of digital health.

The Winter School brought together students, researchers, enterprises, and academic partners to explore innovative health technologies through keynote sessions, teamwork, ideation, prototyping, and final concept presentations. Activities focused on bridging academic knowledge with real-world healthcare challenges, encouraging interdisciplinary collaboration and practical experimentation.

During the programme, Aristotle University of Thessaloniki (AUTH) presented EVOLVE2CARE as a concrete example of a European HealthTech project supporting Living Lab–based experimentation and Open Science practices. The presentation highlighted how EVOLVE2CARE contributes to transparent and responsible innovation in transitional care, while actively engaging with Open Science principles.

In particular, AUTH showcased the use of the RAISE platform for uploading and managing datasets generated through Living Lab activities, demonstrating how EVOLVE2CARE supports FAIR data practices and enables responsible data sharing across collaborative research environments.

Through its presence at the Winter School, EVOLVE2CARE strengthened its visibility within academic and innovation communities, while reinforcing its mission to support human-centred, data-aware HealthTech solutions that can be tested and refined in real-life settings.

EVOLVE2CARE Featured at the RAISE Final Event in Brussels

EVOLVE2CARE was featured during the RAISE Final Event – “Exploitable Results and their Impact”, held on 14 January 2026 in Brussels, as part of the midday session dedicated to the adoption of RAISE beyond project boundaries. The event brought together European research, Living Lab, and Open Science stakeholders to discuss how RAISE supports FAIR, harmonised, and transparent data use across third-party initiatives and collaborative ecosystems.

During the session, EVOLVE2CARE was presented by AUTH and ENoLL partners as a concrete example of a HealthTech project leveraging RAISE functionalities to align with Open Science and Open Data principles, particularly in the context of Living Lab activities. The presentation highlighted how EVOLVE2CARE exploits RAISE to support structured data management, facilitate collaboration between SMEs and Living Labs, and ensure FAIR handling of data generated through real-world experimentation.

The project’s contribution was positioned within a broader discussion involving Living Labs and European networks adopting RAISE to enable interoperable, trustworthy, and reusable research outputs. This visibility further reinforced EVOLVE2CARE’s role as an active adopter of EOSC-aligned tools and practices, strengthening its engagement with European Open Science infrastructures and sister EU initiatives.

From Testing to Adoption: What Makes HealthTech Solutions Ready for Real-World Deployment?

HealthTech innovation rarely fails because of a lack of ideas.
More often, it fails in the space between testing and adoption.

Many promising solutions perform well in pilot environments but struggle to scale, integrate into real healthcare settings, or gain long-term acceptance. The challenge is not proving that a technology works. The real challenge is proving that it is ready.

At EVOLVE2CARE, readiness is understood as a multi-dimensional journey, rather than just a final checkbox. Real-world deployment depends on whether solutions can respond to the practical, organisational, social, and regulatory realities of transitional care.

This blog builds on insights from Deliverable D1.2 – Stakeholder Needs Analysis and KPI Framework, which is publicly available and provides a deeper look into what makes HealthTech solutions ready for real-world deployment.

Why successful pilots don’t always lead to adoption

Testing a HealthTech solution in isolation can demonstrate technical feasibility, but real-world healthcare environments are far more complex.

Healthcare professionals operate under time pressure, fragmented systems, and strict accountability requirements. Hospitals must ensure that new solutions integrate smoothly into existing workflows without increasing workload or disrupting care delivery. Patients and caregivers need technologies that are understandable, usable, and supportive.

When these realities are not addressed early, innovations risk remaining “pilot-ready” but not system-ready.

Readiness starts with real-world relevance

A solution is ready for adoption when it demonstrates value where care actually happens.

Real-life experimentation helps innovators understand whether their solutions:

  • integrate into existing digital and organisational infrastructures
  • reduce administrative burden instead of adding complexity
  • support clinical decision-making in meaningful ways
  • improve patient experience, continuity of care, and outcomes

Living Labs play a critical role here by offering environments where innovations can be tested under realistic conditions, involving healthcare professionals, patients, caregivers, and organisations from the outset. This early exposure allows innovators to identify gaps, refine features, and adapt their solutions long before large-scale deployment.

Scaling requires more than technical performance

Moving beyond pilots requires attention to scale, sustainability, and long-term viability.

Healthcare organisations increasingly expect evidence that innovations are:

  • cost-effective and operationally efficient
  • adaptable to different care settings and regions
  • supported by training and knowledge transfer
  • aligned with broader health system goals

Regulatory preparedness as part of readiness

Regulatory compliance is often addressed late in the innovation process, creating delays and costly redesigns. However, readiness for deployment also means regulatory readiness.

Testing solutions in real-world settings helps innovators:

  • understand how regulations apply in practice
  • identify compliance challenges early
  • align development choices with safety, privacy, and legal requirements

Human-centred adoption

Readiness is ultimately about people.

Patients and caregivers have highlighted the importance of preserving human connection, clarity, and trust when digital solutions are introduced. Healthcare professionals have stressed the need for tools that support their expertise. Care organisations seek solutions that align with their operational realities.

Real-life experimentation allows these perspectives to shape innovation, ensuring that adoption is not forced, but earned through relevance and usability.

EVOLVE2CARE’s work on stakeholder needs and experimentation offers further insight into how readiness can be approached systematically across the HealthTech ecosystem. Readers interested in the methodological foundations behind this approach can further explore our public Deliverable D1.2 – Stakeholder Needs Analysis and KPI Framework.

EVOLVE2CARE at Open Living Lab Days 2025

Home
Tag Archives: Living Labs

EVOLVE2CARE proudly participated in Open Living Lab Days 2025, the flagship annual event of the European Network of Living Labs (ENoLL), held in Andorra la Vella from September 30 to October 3, 2025. This year’s edition embraced a unique concept—transforming an entire country into a Living Lab—making Andorra a dynamic testing ground for innovation.

Under the theme “Living Labs for Regenerative Futures: Connecting Local and Global Innovation Ecosystems,” the event brought together Living Lab professionals, public officials, corporate leaders, entrepreneurs, academics, and innovators from around the world. Discussions focused on how Living Labs can go beyond sustainability to regenerate ecological, social, and economic systems actively.

EVOLVE2CARE had a strong and impactful presence, represented by key members from ENoLL and Aristotle University of Thessaloniki (AUTH):

  • Marta I. De Los Rios White and Francesca Sperandio (ENoLL), who contributed to the organization and networking activities.
  • Evdokimos Konstantinidis, Project Coordinator of EVOLVE2CARE and Vice Chair of ENoLL (AUTH), presented the research paper “Optimizing Data Collection Planning for Living Labs’ Access and Effectiveness”. 
  • Despoina Petsani, Project Mission Coordinator (AUTH) of EVOLVE2CARE, who presented the paper “Defining the Role of Living Labs to Clinical Research: Initial Findings for Framework Development.”
  • EVOLVE2CARE members supported the session “Bridging the Gap Between Living Labs and Companies: Towards a Stronger Collaboration Relationship.”

In addition, EVOLVE2CARE was featured at the ENoLL Valorisation Booth, showcasing its mission to accelerate HealthTech innovation through experimentation and collaboration between Living Labs and innovators. Our active participation reflects EVOLVE2CARE’s commitment to fostering collaboration between Living Labs and health innovation ecosystems, paving the way for solutions that regenerate and thrive.

Measuring impact & Evaluating success: A recap of the final training session for Living Labs

Home
Tag Archives: Living Labs

The sixth and final webinar of the EVOLVE2CARE Training Series for Living Labs took place on 19 September 2025, with a focus on measuring impact and scaling pilots. This session, titled “Measuring Impact & Evaluating Success”, was led by Prof. Dr. Dimitri Schuurman, Senior Research Strategist at the European Network of Living Labs (ENoLL).

Key takeaways from the session

Understanding Living Lab characteristics

Prof. Schuurman emphasized the core elements that define a Living Lab, which include:

  • Multi-stakeholder: Living Labs engage a diverse group of stakeholders, including researchers, businesses, governments, and end-users. This broad collaboration ensures that innovation is inclusive and relevant to all parties involved.
  • Active user involvement: Ensuring the continuous feedback of users throughout the innovation process, from idea generation to final implementation.
  • Orchestration: Orchestration refers to the strategic coordination of all actors in the Living Lab. By aligning the interests and expertise of different stakeholders, Living Labs facilitate effective collaboration and drive the innovation process forward.
  • Co-Creation: Involving all relevant stakeholders in the design and development processes.
  • Real-Life Setting: Unlike traditional laboratories, Living Labs test solutions in real environments, which increases the relevance and applicability of the results.
  • Multi-Method Approach: Each Living Lab adapts its methods based on the problem and stakeholders involved, blending exploratory and confirmatory approaches.

Impact Models and Measuring Outcomes

One of the central frameworks discussed during the session was the Impact Model. This model is essential for understanding how to track the effectiveness of Living Labs over time. It incorporates the Theory of Change, which categorizes results into:

  • Input: Resources and efforts that go into the project.
  • Process: The activities and interactions that drive the project forward.
  • Output (Short-Term): Direct deliverables and tangible results produced immediately after implementation.
  • Outcome (Medium-Term): The effects of those outputs on the targeted stakeholders or systems.
  • Impact (Long-Term): The ultimate, lasting change or influence of the project, contributing to broader societal goals.

This model helps Living Labs track not just the immediate outputs, but also the long-term impacts, offering a roadmap for continuous improvement.


Living Lab Assessment Method


To effectively evaluate the impact of Living Lab projects, the Living Lab Assessment Method was introduced. It is designed to measure the effectiveness across six key areas:

  • Skill Capacity Enhancement
  • Instrumental Capacity Enhancement
  • Network Capacity Enhancement
  • Knowledge Capacity Enhancement
  • Agenda Setting
  • Real Solution Generation

These indicators are critical for understanding how well a Living Lab is contributing to innovation and systemic change in its targeted sector.
A heartfelt thank you to all participants who joined us for the six-part EVOLVE2CARE Training Program for Living Labs led by ENoLL from June to September 2025. Your engagement and contributions made this series a great success. In the coming weeks, all the session recordings will be made available at the ENoLL Living Labbers Academy, so you can revisit the valuable insights shared throughout the program. We look forward to continuing the journey of innovation with you!